Moneycontrol PRO
Outskill Genai
HomeNewsBusinessSell Aurobindo Pharma, target Rs 485: Vinay Rajani

Sell Aurobindo Pharma, target Rs 485: Vinay Rajani

We recommend selling Aurobindo Pharma for the downside target of Rs 485 with a stop loss placed at Rs 570.

June 05, 2018 / 11:59 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Vinay Rajani

    Aurobindo Pharma has broken down from the long-term upward sloping trend line. The price has been forming the lower top and lower bottom formation on the weekly chart.

    The stock has been trading below the short-term and long-term moving averages. Volumes have been rising along with the price fall.

    Oscillators have been showing weakness on the daily as well as weekly charts. Bearish rounding top formation is witnessed on the weekly charts.

    We recommend selling Aurobindo Pharma for the downside target of Rs 485 with a stop loss placed at Rs 570.

    Disclaimer: The author is Technical Analyst, PCG Desk, HDFC Securities. The views and investment tips expressed by investment expert on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment
    decisions.

    Moneycontrol News
    first published: Jun 5, 2018 11:59 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347